Demethoxycapillarisin (6-Demethoxycapillarisin) inhibits PEPCK mRNA levels ( IC 50 : 43 μM) by activation of the PI3K pathway. Demethoxycapillarisin decreases glucose production.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PEPCK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.